Article Information
History
- June 15, 2020.
Article Versions
- Version 1 (April 9, 2020 - 12:54).
- Version 2 (May 19, 2020 - 01:21).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Rongrong Chen1,
- Keer Wang1,
- Jie Yu1,
- Derek Howard2,
- Leon French2,
- Zhong Chen3,4,
- Chengping Wen1,* and
- Zhenghao Xu1,*
- 1Institute of TCM Clinical Basic Medicine, School of Basic Medical Science, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China
- 2Krembil Centre for Neuroinformatics, Centre for Addiction and Mental Health, Toronto, Ontario, Canada
- 3Zhejiang Chinese Medical University, Hangzhou, Zhejiang, China
- 4Key Laboratory of Medical Neurobiology of National Health Commission and Chinese Academy of Medical Sciences, Institute of Pharmacology and Toxicology, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China
- ↵*Corresponding Author: Chengping Wen, PhD, MD. Binwen Road 548, Hangzhou, Zhejiang, China, tel & fax: +86-571-86613587, e-mail: wengcp{at}163.com, Zhenghao Xu, PhD. Binwen Road 548, Hangzhou, Zhejiang, China, tel & fax: +86-571-86613587, e-mail: xuzhenghao{at}zcmu.edu.cn;
The first three authors contribute equally.
Posted June 15, 2020.
The spatial and cell-type distribution of SARS-CoV-2 receptor ACE2 in human and mouse brain
